BR112022026479A2 - Preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural - Google Patents

Preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural

Info

Publication number
BR112022026479A2
BR112022026479A2 BR112022026479A BR112022026479A BR112022026479A2 BR 112022026479 A2 BR112022026479 A2 BR 112022026479A2 BR 112022026479 A BR112022026479 A BR 112022026479A BR 112022026479 A BR112022026479 A BR 112022026479A BR 112022026479 A2 BR112022026479 A2 BR 112022026479A2
Authority
BR
Brazil
Prior art keywords
immune
natural
accelerate
administration
enhance
Prior art date
Application number
BR112022026479A
Other languages
English (en)
Inventor
E Steffek Amy
A Dahl Andrew
P Pfund William
Original Assignee
Zivo Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zivo Bioscience Inc filed Critical Zivo Bioscience Inc
Publication of BR112022026479A2 publication Critical patent/BR112022026479A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)

Abstract

preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural. são revelados um método e um composto para alterar o estado das vias imunes inata e adaptativa em animais e humanos. a alteração de estado resulta na preparação da resposta imune, por meio da qual uma resposta acelerada e mais robusta é gerada quando o animal ou humano é desafiado por patógenos que levam a um amplo intervalo de estados de doença. o método revelado utiliza um composto derivado de um lipopolissacarídeo (lps) de bactéria gram-negativa. o composto em si é um produto natural sem impacto ambiental adverso observado. ao preparar as vias imunes de acordo com o conceito inventivo revelado, a gravidade de vários estados da doença pode ser reduzida, pode ser resolvida mais rapidamente ou pode ser totalmente evitada.
BR112022026479A 2020-06-26 2021-06-25 Preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural BR112022026479A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063044841P 2020-06-26 2020-06-26
PCT/US2021/039180 WO2021263162A1 (en) 2020-06-26 2021-06-25 Immune priming to accelerate/enhance immune response through administration of natural immune modulator
US17/358,878 US20220016240A1 (en) 2020-06-26 2021-06-25 Immune priming to accelerate/enhance immune response through administration of natural immune modulator

Publications (1)

Publication Number Publication Date
BR112022026479A2 true BR112022026479A2 (pt) 2024-03-05

Family

ID=79281956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022026479A BR112022026479A2 (pt) 2020-06-26 2021-06-25 Preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural

Country Status (8)

Country Link
US (1) US20220016240A1 (pt)
JP (1) JP2023532023A (pt)
AU (1) AU2021296916A1 (pt)
BR (1) BR112022026479A2 (pt)
CA (1) CA3182630A1 (pt)
MX (1) MX2023000158A (pt)
PE (1) PE20231653A1 (pt)
WO (1) WO2021263162A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022022083A2 (pt) * 2020-05-14 2022-12-13 Zivo Bioscience Inc Uso de modulador de tlr4 no tratamento de coccidiose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3684295D1 (de) * 1985-12-03 1992-04-16 Solvay Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose.
ES2330300T3 (es) * 1999-03-26 2009-12-09 Genichiro Soma Aditivos para alimentos para crustaceos o peces y alimentos.
EA018687B1 (ru) * 2005-11-28 2013-09-30 Байомедикал Рисерч Груп Инк. Фракция гликолипидов ферментированных экстрактов биологического пищевого материала и фармацевтическая композиция, содержащая указанную фракцию
US10632157B2 (en) * 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
CA3011788A1 (en) * 2016-01-19 2017-07-27 Bioconsortia, Inc. Agriculturally beneficial microbes, microbial compositions, and consortia
MX2017016809A (es) * 2017-12-19 2018-07-12 Ivan Ernesto Villavicencio Gomez Uso de formulaciones nutracéuticas para la elaboración de suplementos alimenticios para la industria animal, que emplean substancias naturales como minerales, productos botánicos aceites esenciales y vitaminas con bacterias y enzimas.
MX2021007359A (es) * 2018-12-21 2021-10-13 Zivo Bioscience Inc Ingrediente alimenticio de algas para controlar los efectos de coccidiosis y la enteritis necrotica en aves de corral.

Also Published As

Publication number Publication date
PE20231653A1 (es) 2023-10-17
WO2021263162A1 (en) 2021-12-30
MX2023000158A (es) 2023-02-16
JP2023532023A (ja) 2023-07-26
AU2021296916A1 (en) 2023-01-19
CA3182630A1 (en) 2021-12-30
US20220016240A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
Di Lorenzo et al. Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions
BR112022026479A2 (pt) Preparação imune para acelerar/aprimorar a resposta imune por meio da administração de modulador imune natural
BR112022003154A2 (pt) Agente imunobiológico para induzir a imunidade específica contra o vírus da síndrome respiratória aguda grave sars-cov-2
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
BR112018010505A2 (pt) mistura de oligossacarídeos de leite humano (hmos)
BR112016024850A2 (pt) composições e métodos para modulação da expressão 3 semelhante a antiopoietina
BR112015032918A8 (pt) células encapsuladas liofilizadas, métodos para sua liofilização e para sua preparação, seus usos, e composições
BR112022007568A2 (pt) Análogo de carne moída, método para preparar um análogo de carne moída e processo para preparar um análogo de carne moída
BR112018072064A2 (pt) composições nutricionais para proteção cardíaca em animais de estimação
BR112022004040A2 (pt) Sistema para gerar dados animais simulados e modelos
BR112017012682A2 (pt) processo para aperfeiçoamento de porções de músculo e produtos
BR112017028428A2 (pt) ?produto de confeitaria congelado?
BR112015017083A2 (pt) partículas secas por aspersão com vida de prateleira estável
BR112018077433A2 (pt) processo para preparação de polímeros de ácido acrílico sólidos, e, solução aquosa de polímero de ácido acrílico pelo menos parcialmente neutralizada .
BR112017014649A2 (pt) ?isolado intestinal humano, e, composição?
BR112018013292A2 (pt) ?método para preparar uma preparação de e. hallii e para promover formação de ácido butírico, e, preparação de e. hallii?
EA202193158A1 (ru) Определение и выбор растительного исходного материала для растительного хондроитинсульфата и гиалуроновой кислоты и преобразование такого растительного исходного материала с получением ингредиентов для применения в пищевых продуктах, добавках, медицинских устройствах или лекарствах
BR112023001738A2 (pt) O uso de micróbios variovorax como tratamento alternativo para coccidiose
BR112022002663A2 (pt) Método e sistema em uma máquina florestal
BR112019000418A2 (pt) composição, método de tratamento de um sujeito, e, kit.
BR112018074841A2 (pt) tablete de bouillon duro
JP2020501558A5 (pt)
BR112022021475A2 (pt) Composição de herbicida de sulfonilureia líquida
BR112018010907A2 (pt) polímero de emulsão aquosa de múltiplos estágios, e, composição aquosa de revestimento.
BR112021023865A2 (pt) Composições imunogênicas